興科蓉醫藥(06833.HK)已補救內部監控缺陷 風險可控
興科蓉醫藥(06833.HK)公布,內部監控顧問已向獨立委員會提交最終內部監控檢討報告,發現合共5個主要內部監控缺陷,其中3個分類為中風險,其餘2個分類為低風險,當中涉及供應商信息管理、供應商背景調查、資金管理流程等範圍。公司已採取整改措施處理主要內部監控缺陷。
獨立委員會及董事會認為,主要內部監控缺陷已獲補救,相關風險亦已控制至合理可接受水平,公司所採取的補救行動及改善措施,已足夠及充分應對內部監控檢討報告的主要發現結果。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.